SCHEMBL28082173

SCHEMBL28082173

COc1cccc(NC(=O)Nc2ccc(NS(C)(=O)=O)cc2)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.74
TP53 P04637 2/20 0.74
RAB9A P51151 9/20 0.65
MAPT P10636 8/20 0.65
NPC1 O15118 7/20 0.65
SMN1; SMN2 Q16637 6/20 0.65
KMT2A Q03164 5/20 0.65
HTT P42858 5/20 0.65
LMNA P02545 3/20 0.65
MEN1 O00255 3/20 0.65
MAPK1 P28482 2/20 0.65
STAT1 P42224 1/20 0.65
ALDH1A1 P00352 3/20 0.64
ALOX15 P16050 2/20 0.64
CASP3 P42574 1/20 0.62
SENP7 Q9BQF6 1/20 0.62
RAF1 P04049 1/20 0.61
IDH1 O75874 1/20 0.61
MITF O75030 1/20 0.60
CNR1 P21554 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28082142 0.85 RAB9A (0.73) TSHRTP53RAB9AMAPTNPC1
SCHEMBL4893387 0.85 TP53 (0.87) TSHRTP53RAB9AMAPTNPC1
SCHEMBL31040569 0.85 TP53 (0.87) TSHRTP53RAB9AMAPTNPC1
SCHEMBL14442613 0.84 TP53 (0.84) TSHRTP53RAB9AMAPTNPC1
SCHEMBL17084260 0.83 TP53 (0.84) TSHRTP53RAB9AMAPTNPC1
SCHEMBL309673 0.83 LMNA (0.60) TSHRSMN1; SMN2KMT2AHTTLMNA
SCHEMBL5852120 0.82 TP53 (0.82) TSHRTP53RAB9AMAPTNPC1
SCHEMBL21750961 0.82 TSHR (0.82) TSHRTP53RAB9AMAPTNPC1
SCHEMBL22103791 0.82 TSHR (0.82) TSHRTP53RAB9AMAPTNPC1
Hydrochloric Acid SCHEMBL20502482 0.82 LMNA (0.59) TSHRTP53SMN1; SMN2KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103570723-B Pyrazolopyrimidine derivative and preparation method thereof and the purposes in prepared by medicine 广西梧州制药(集团)股份有限公司 2016-07-13 CN disclosed